Updates on Novel Pharmacotherapeutics for the Treatment of Nonalcoholic Steatohepatitis

The authors summarize the latest data of new medications which have completed phase II or III trials for the treatment of nonalcoholic steatohepatitis, and discuss the rationale and preliminary results of several combinatory options.